Successful Pregnancies After Adequate Hormonal Replacement in Patients With Combined Pituitary Hormone Deficiencies (original) (raw)

Does pituitary suppression affect live birth rate in women with congenital hypogonadotrophic hypogonadism undergoing intra-cytoplasmic sperm injection? A multicenter cohort study

kiper aslan

Gynecological Endocrinology, 2017

View PDFchevron_right

Some clinical aspects of pituitary-ovarian relationships in women with ovulatory infertility

I. Cooke

Reproduction, 1977

View PDFchevron_right

Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction

Ehab I. Mohamed

Gynecological Endocrinology, 2005

View PDFchevron_right

The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature

Antonio Bianchi

Fertility and Sterility, 2009

View PDFchevron_right

Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome

fernando bonilla

Human Reproduction, 1999

View PDFchevron_right

Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients

Monika Seifert

Human reproduction (Oxford, England), 2015

View PDFchevron_right

The Reproductive Performance of Women With Hypogonadotropic Hypogonadism In An In Vitro Fertilization and Embryo Transfer Program

ulun ulug

Journal of Assisted …, 2005

View PDFchevron_right

Management of ovulation induction and intrauterine insemination in infertile patients with hypogonadotropic hypogonadism

Berk Bulut

Journal of gynecology obstetrics and human reproduction, 2019

View PDFchevron_right

Successful pregnancy after ovulation induction with human chorionic gonadotropin in a woman with selective luteinising hormone deficiency

Alberto Zaconeta

Human Reproduction, 2021

View PDFchevron_right

Improved in Vitro Fertilization Outcomes after Treatment of Subclinical Hypothyroidism in Infertile Women

Hadeer Ashraf

Endocrine Practice, 2010

View PDFchevron_right

Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction

Dolors Manau

Reproductive BioMedicine Online, 2003

View PDFchevron_right

Predictors of Total Gonadotropin Dose Required for Follicular Growth in Controlled Ovarian Stimulation with Intrauterin Insemination Cycles in Patients with Unexplained Infertility or Male Subfertility

mehmet çınar

Gynecology Obstetrics and Reproductive Medicine, 2011

View PDFchevron_right

Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression

Daniela Braga de Souza

Fertility and Sterility, 2010

View PDFchevron_right

SUCCESSFUL PREGNANCY IN A WOMAN WITH HYPOGONADOTROPIC HYPOGONADISM AFTER CONTROLLED OVARIAN STIMULATION AND INTRAUTERINE INSEMINATION

Manish Thakur

View PDFchevron_right

Outcome of in vitro fertilization in women with subclinical hypothyroidism

BIOLOGIA DE LA REPRODUCCION UMAE 23

View PDFchevron_right

In-Vitro Fertilization Outcome Predictors in Women With High Baseline Follicle-Stimulating Hormone Levels: Analysis of Over 1000 Cycles From A Tertiary Center

Aysin Akdogan

JBRA Assisted Reproduction

View PDFchevron_right

High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment

Frank Broekmans

Fertility and Sterility, 2004

View PDFchevron_right

A successful conception by a shift from human menopausal gonadotropin therapy to therapy with recombinant human follicular-stimulating hormone for the treatment of male hypogonadotropic hypogonadism

Teruo Inamoto

Reproductive Medicine and Biology, 2010

View PDFchevron_right

Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization

MARTHA LUNA

Fertility and Sterility, 2007

View PDFchevron_right

A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization

Howard Jacobs

International Journal of Gynecology & Obstetrics, 1993

View PDFchevron_right

Is growth hormone administration essential for in vitro fertilization treatment of female patients with growth hormone deficiency?

Alice Albu

Systems biology in reproductive medicine, 2018

View PDFchevron_right

The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotropin in a panhypopituitary patient

Zeev Blumenfeld

Fertility and Sterility, 1989

View PDFchevron_right

To Compare the Levels of Reproductive Hormones and TSH in Females with Primary Infertility and Early Pregnancy Loss

Monica Verma

International Journal of Advanced Research, 2018

View PDFchevron_right

The clinical efficacy of low-dose step-up follicle stimulating hormone administration for treatment of unexplained infertility

Kazuhiko Tsuchiya

Human Reproduction, 1999

View PDFchevron_right

Impact of preconceptional serum thyroid stimulating hormone values ranging between 2.5 and 4.5 mIU/L on live birth rates following ovulation induction and intrauterine insemination treatment for unexplained infertility

Cagdas Ozdemir

BMC Women's Health, 2021

View PDFchevron_right

Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration

Micah Hill

Fertility and Sterility, 2011

View PDFchevron_right

Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients

F. Fábregues, Ricard Vidal

Journal of assisted reproduction and genetics, 1998

View PDFchevron_right